Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCRB00579
2018-01-17
Prospective
N.A.
Direct Grant CUHK
Hon KL, sponsored by Direct Grant CUHK
N.A.
Not Applicable
Esther Lam
Department of Paediatrics, 6/F Prince of Wales Hospital, Shatin
35052982
esther-lam@cuhk.edu.hk
Hospital Authority
Hong Kong, China
Kam Lun HON
Department of Paediatrics, 6/F Prince of Wales Hospital, Shatin
35052856
ehon@cuhk.edu.hk
The Chinese University of Hong Kong
Hong Kong, China
Effect of pine-tar shower on itch and diseae severity in moderate-to-severe childhood eczema
Effect of pine-tar shower on childhood eczema
松焦油沐浴對濕疹病童接受水平及金黃葡萄球菌的治療情況
Omit
Hong Kong, China
Yes
2017-08-24
Joint CUHK-NTEC Clinical Research Ethics Committee
2017.399-T
Eczema
Other
Pine tar bath oil
Product name: Pinetarsol
(pine tar bath oil 2.3% w/w)
N.A.
10-20ml daily
4 weeks (active arm)
10-15 min. daily
Placebo: QV Baby Bath Oil
N.A.
10-20ml daily
4 weeks
10-15 min. daily
- only patients with moderate-to-severe eczema of SCORAD (SCORing Atopic Dermatitis) scores >15 points will be recruited
- Subjects (patients and parents) have intercurrent illness for two weeks prior to study
- received any systemic antibiotics for at least 4 weeks prior
- subject with documented allergies to study product components
- subject enrolled in another clinical trial during the study period
- subject/parent considered by teh investigator to be likely not compliant to be likely not compliant to the protocol
3
18
Both Male and Female
Interventional
Randomized
through computerized randomization generated by a research staff not involved in the trial.
Placebo
Single-blind
Investigator/research team
Crossover
Other
N.A.
2018-01-31
40
Not Yet Recruiting
eczema severity
by SCORAD (SCORing Atopic Dermatitis); modified POEM (Patient Oriented Eczema Measure)
S. aureus status (absent, scantly, moderate, heavy growth) during the study period
by skin swab
Skin hydration (SH) and transepidermal water loss (TEWL)
by MoistureMeterSC and Vapometer (Delfin Technologies Ltd, Kuopio, Finland)
Quality of life
by CDLQI (Children's Dermatology Life Quality Index)
Eczema severity blood markers (eg. ige, eosinophils)
2018-01-25
|
|
|
|
|
---|---|---|---|---|
No documents yet. |